The Marburg I polymorphism of factor VII–activating protease and the risk of venous thromboembolism

Volker Weisbach; Renate Ruppel; Reinhold Eckstein

doi:10.1160/TH06-12-0739

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 97(05): 870-872
DOI: 10.1160/TH06-12-0739

Letters to the Editor

Schattauer GmbH

The Marburg I polymorphism of factor VII–activating protease and the risk of venous thromboembolism

Volker Weisbach

¹Department of Transfusion Medicine and Haemostaseology, University Hospital of Erlangen-Nuremberg, Erlangen, Germany

,

Renate Ruppel

¹Department of Transfusion Medicine and Haemostaseology, University Hospital of Erlangen-Nuremberg, Erlangen, Germany

,

Reinhold Eckstein

¹Department of Transfusion Medicine and Haemostaseology, University Hospital of Erlangen-Nuremberg, Erlangen, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Römisch J. FVII activating protease (FSAP): novel protease in haemostasis. Biol Chem 2002; 383: 1119-1124.
2 Hoppe B, Tolou F, Radtke H. et al. Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism. Blood 2005; 105: 1549-1551.
3 van Minkelen R, de Visser MCH, Vos HL. et al. The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis. Blood 2005; 105: 4898-4899.
4 Franchi F, Martinelli I, Biguzzi E. et al. Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism. Blood 2006; 107: 1731
5 Hoppe B, Heymann GA, Radtke H. et al. Association of Marburg I polymorphism of factor VII-activating protease with venous thromboembolism is limited to idiopathic events. Blood 2005; 105: 4899
6 Gulesserian T, Hron G, Endler G. et al. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 2006; 95: 65-67.
7 Hoppe B, Dorner T, Kiesewetter H. et al. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 2006; 95: 907-908.
8 Kyrle PA. Response to: Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 2006; 95: 908
9 Bertina RM, Koeleman BP, Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
10 Poort SR, Rosendaal FR, Reitsma PH. et al. A common genetic variation in the 3V-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3.